Evogene Reports Q4 Loss, Misses Revenue Estimates

EVGN Stock  USD 0.63  0.03  4.55%   
About 53% of Evogene's investor base is interested to short. The analysis of the overall investor sentiment regarding Evogene suggests that many traders are impartial. Evogene's investor sentiment overview provides quick insight into current market opportunities from investing in Evogene. The current market sentiment, together with Evogene's historical and current headlines, can help investors time the market. In addition, many technical investors use Evogene stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Evogene stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Evogene daily returns and investor perception about the current price of Evogene as well as its diversification or hedging effects on your existing portfolios.
  
Evogene delivered earnings and revenue surprises of 7.14 percent and 66.59, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock

Read at finance.yahoo.com
Yahoo News
  

Evogene Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Evogene can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Evogene Fundamental Analysis

We analyze Evogene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Evogene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Evogene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Book

Price To Book Comparative Analysis

Evogene is currently under evaluation in price to book category among related companies. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Evogene Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Evogene stock to make a market-neutral strategy. Peer analysis of Evogene could also be used in its relative valuation, which is a method of valuing Evogene by comparing valuation metrics with similar companies.

Peers

Evogene Related Equities

BDRXBiodexa Pharmaceticals   80.56   
0%
100.0%
CLGNCollplant Biotechnologies   9.89   
0%
12.0%
PLURPluri   9.39   
0%
11.0%
CRVSCorvus Pharmaceuticals   8.97   
0%
11.0%
LEXXLexaria Bioscience   7.31   
0%
9.0%
RCUSArcus Biosciences   5.57   
0%
6.0%
PLXProtalix Biotherapeutics   4.35   
0%
5.0%
CANFCan Fite   3.13   
0%
3.0%
ALDXAldeyra   3.05   
0%
3.0%
CGENCompugen   1.05   
0%
1.0%
ICCCImmuCell   0.78   
0%
1.0%
CKPTCheckpoint Therapeutics   0.70   
0%
1.0%
FATEFate Therapeutics   1.81   
2.0%
0%
ZVSAZyVersa Therapeutics   17.93   
22.0%
0%
When determining whether Evogene offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evogene's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evogene Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evogene Stock:
Check out Evogene Hype Analysis, Evogene Correlation and Evogene Performance.
To learn how to invest in Evogene Stock, please use our How to Invest in Evogene guide.
Note that the Evogene information on this page should be used as a complementary analysis to other Evogene's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for Evogene Stock analysis

When running Evogene's price analysis, check to measure Evogene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evogene is operating at the current time. Most of Evogene's value examination focuses on studying past and present price action to predict the probability of Evogene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evogene's price. Additionally, you may evaluate how the addition of Evogene to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Is Evogene's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evogene. If investors know Evogene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evogene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.52)
Revenue Per Share
0.123
Quarterly Revenue Growth
(0.12)
Return On Assets
(0.31)
Return On Equity
(0.82)
The market value of Evogene is measured differently than its book value, which is the value of Evogene that is recorded on the company's balance sheet. Investors also form their own opinion of Evogene's value that differs from its market value or its book value, called intrinsic value, which is Evogene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evogene's market value can be influenced by many factors that don't directly affect Evogene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evogene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evogene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evogene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.